Journal Guide

Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application).

The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review.

Sustainable Chemistry and Pharmacy is an international journal suitable for the publication of original communications as well as review articles. In this it has a wide general appeal and accepts the full spectrum of high quality manuscripts from short communications to extended research papers as well as review articles. Papers describing new concepts or contributing to a better understanding of concepts related to sustainable chemistry and pharmacy are highly welcome. Papers should be of originality, novelty and uniqueness. A short communication should present a novel finding that warrants immediate publication.

All manuscripts must be written so as to be widely accessible and understandable to interdisciplinary and trans disciplinary oriented readers without neglecting the disciplinary excellence and clearness.

Sustainable Chemistry and Pharmacy does not publish research associated with 'end-of-pipe' or remediation issues, if they are not clearly related to sustainability.

Letters to the editor and discussion papers are welcome in order to provide a forum for discussions on a high scientific level. Additionally, a news section provides an interesting variety of news, facts, forthcoming events and conferences as well as book reviews.

In a highly competitive industry, Therapeutic Delivery provides the busy researcher with a forum for the rapid publication of original research and critical reviews of all the latest relevant and significant developments, and focuses on how the technological, pharmacological, clinical and physiological aspects come together to successfully deliver modern therapeutics to patients. The journal delivers this essential information in concise, at-a-glance article formats that are readily accessible to the full spectrum of therapeutic delivery researchers.

AJOL is a web platform for African-published journals. It is a partnership of journals committed to increasing the international profile of Africa's scholarly work and improving access to African-originated knowledge. By joining together as a large group of journals, this service has attained great international recognition, and visibility on the internet.